The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
KRKA holds 51% and Laurus Labs holds 49% shareholding
The company plans to add 1700 beds by FY27 through the organic route
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Cipla completes transfer of Generics Business Undertaking
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
The registered capital of the newly founded company is € 50 million
Subscribe To Our Newsletter & Stay Updated
